Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at radiotherapy with and without temozolomide for anaplastic glioma (CATNON; EORTC 26053-22054)

Overview

Cancer types:

Brain (and spinal cord) tumours

Status:

Results

Phase:

Phase 3

Details

This trial compared radiotherapy alone to radiotherapy and temozolomide for a type of brain tumour called anaplastic glioma.

The trial was supported by Cancer Research UK. It was open for people to join between 2007 and 2015. The team have published results in several medical journals. They plan to publish more results in the future.

Recruitment start: 4 December 2007

Recruitment end: 11 September 2015

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Sara Erridge

Supported by

Cancer Research UK

European Organisation for Research and Treatment of Cancer (EORTC)

Experimental Cancer Medicine Centre (ECMC)

Medical Research Council Clinical Trials Unit at University College London (MRC CTU at UCL)

Merck Sharp and Dohme (MSD)

NIHR Clinical Research Network: Cancer

Schering Plough

Other information

This is Cancer Research UK trial number CRUK/07/028.

Last reviewed: 21 March 2025

CRUK internal database number: 796

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.